Clearbridge BioMedics and Leica Biosystems to co-market automated solutions for circulating tumour cell (CTC) analysis
Clearbridge BioMedics and Leica Biosystems have today announced a partnership, co-marketing each other’s products to support circulating tumour cell (CTC) research. This is specifically for the Clearbridge BioMedics ClearCell® FX CTC enrichment system and the Leica Biosystems’ BOND RX staining platform. This new partnership provides an integrated and automated workflow for CTC enrichment and immunostaining, […]

